| MR编号 | AT/H/0587/001 |
|---|
| 药品名称 | Bendamustin Kabi 2.5 mg/ml powder for concentrate for solution for infusion |
|---|
| 活性成分 | - Bendamustine hypochloride 2.5 mg/ml
|
|---|
| 剂型 | Powder for concentrate for solution for infusion |
|---|
| 上市许可持有人 | Fresenius Kabi Austria GmbH,
Hafnerstraße 36
A-8055 Graz
Austria |
|---|
| 参考成员国 - 产品名称 | Austria (AT) Bendamustin Kabi 2.5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
|---|
| 互认成员国 - 产品名称 | - Denmark (DK)
- Ireland (IE)
- Spain (ES)
- Portugal (PT)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Bendamustine Kabi - Latvia (LV)
Bendamustine Kabi 2,5 mg/ml pulveris infūziju šķīduma koncentrāta pagatavošanai - Estonia (EE)
BENDAMUSTINE KABI - Hungary (HU)
BENDAMUSTINE KABI 2,5 mg/ml por oldatos infúzióhoz való koncentrátumhoz - Czechia (CZ)
BENDAMUSTINE KABI 2,5 MG/ML - Slovakia (SK)
Bendamustine Kabi 2,5 mg/ml - Slovenia (SI)
Bendamustin Kabi 2,5 mg/ml prašek za koncentrat za raztopino za infundiranje - Malta (MT)
- Croatia (HR)
Bendamustin Kabi 2,5 mg/ml prašak za koncentrat za otopinu za infuziju - Germany (DE)
Bendamustin Kabi 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung - Belgium (BE)
Bendamustine Fresenius Kabi 2,5 mg/ml poeder voor concentraat voor oplossing voor infusie - Luxembourg (LU)
- Netherlands (NL)
- United Kingdom (Northern Ireland) (XI)
- Italy (IT)
- Sweden (SE)
- Lithuania (LT)
Bendamustine Kabi 2,5 mg/ml milteliai infuzinio tirpalo koncentratui
|
|---|
| 许可日期 | 2016/06/22 |
|---|
| 最近更新日期 | 2025/09/22 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|